Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Genome Therapeutics and Cadus join forces in the search for new therapeutic targets

Aug. 19, 1998

Matrix granted Japanese patent; U.S. patent reissued

Aug. 18, 1998

MorphoSys and DuPont Pharmaceuticals sign collaboration agreement

Aug. 14, 1998

Fusion protein enables large-scale production of bioactive carbohydrates

Aug. 14, 1998

Idun to license patent application for apoptosis model

Aug. 13, 1998

Gene screening technology developed at Harvard Medical School licensed to Versicor

Aug. 10, 1998

Label expansion for CEPRATE SC approved

July 31, 1998

Alizyme granted exclusive worldwide license to BTG drug delivery technology

July 31, 1998

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

July 28, 1998

Hybridon and Searle extend and expand antisense research collaboration

July 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...